Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant.

Authors :: Chiba Y
Tasaka K
Matsubara K
Mori M
Muraoka M
Hamabata T
Nodomi S
Waki K
Source :: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jun; Vol. 71 (6), pp. e30953. Date of Electronic Publication: 2024 Mar 22.
Publication Year :: 2024

Subjects :: Humans
Infant
Male
Receptors, Thrombopoietin agonists
Purpura, Thrombocytopenic, Idiopathic drug therapy
Receptors, Fc therapeutic use
Recombinant Fusion Proteins therapeutic use
Thrombopoietin therapeutic use

Full Text Access

Tools